Truist Financial Corp Protara Therapeutics, Inc. Put Options Transaction History
Truist Financial Corp
- $65.3 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TARA
# of Institutions
40Shares Held
4.55MCall Options Held
102KPut Options Held
18.2K-
Opaleye Management Inc. Boston, MA2.69MShares$5.65 Million2.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA428KShares$897,9850.0% of portfolio
-
Boxer Capital, LLC San Diego, CA209KShares$439,3760.04% of portfolio
-
Ikarian Capital, LLC Dallas, TX203KShares$425,6720.11% of portfolio
-
Baker Bros. Advisors LP New York, NY200KShares$419,3090.01% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $23.7M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...